Anterogen Co Ltd
KOSDAQ:065660
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
A
|
Anterogen Co Ltd
KOSDAQ:065660
|
KR |
|
A
|
Alerio Gold Corp
CNSX:ALE
|
CA |
|
S
|
Saigon Fishing Net JSC
VN:SFN
|
VN |
|
M
|
Maquia Capital Acquisition Corp
NASDAQ:MAQC
|
US |
|
C
|
CuraScientific Corp
OTC:CSTF
|
US |
|
Korro Bio Inc
NASDAQ:KRRO
|
US |
|
V
|
VBI Office Fund II FII
BOVESPA:BLMO11
|
BR |
|
M
|
MDI Energia SA
WSE:MDI
|
PL |
|
O
|
Orbis Se
XHAM:OBS
|
DE |
|
C
|
Clearday Inc
OTC:CLRD
|
US |
|
C
|
Capital Park SA
WSE:CPG
|
PL |
|
S
|
Summit Royalties Ltd
XTSX:SUM
|
CA |
|
Hypha Labs Inc
OTC:FUNI
|
US |
|
L
|
Lead Co Inc
TSE:6982
|
JP |
|
L
|
Lansen Pharmaceutical Holdings Ltd
F:1LP
|
CN |
|
Comstock Holding Companies Inc
NASDAQ:CHCI
|
US |
|
S
|
Sharika Enterprises Ltd
BSE:540786
|
IN |
|
Spyrosoft SA
F:2NP
|
PL |
Bankruptcy Probability
Anterogen Co Ltd's probability of bankruptcy is Hidden . The solvency score is Hidden .
We take all the information about a company's solvency, such as how easily it can pay interest on outstanding debt, how much cash it has, the amount of debt, and more, and use it to estimate the probability of bankruptcy.
Solvency Ratios
Solvency Ratios Comparison
Anterogen Co Ltd Competitors
| Country | Company | Market Cap | D/E | D/A |
Interest Coverage |
Altman Z-Score |
Quick Ratio |
Current Ratio |
Cash Ratio |
||
|---|---|---|---|---|---|---|---|---|---|---|---|
| KR |
A
|
Anterogen Co Ltd
KOSDAQ:065660
|
151.5B KRW |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| FR |
|
Pharnext SCA
OTC:PNEXF
|
6T USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| JP |
|
Takara Bio Inc
TSE:4974
|
120.4T JPY |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Abbvie Inc
NYSE:ABBV
|
462.7B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Amgen Inc
NASDAQ:AMGN
|
233.3B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Gilead Sciences Inc
NASDAQ:GILD
|
178B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
|
136.9B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
E
|
Epizyme Inc
F:EPE
|
94.1B EUR |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
|
85.5B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| NL |
|
argenx SE
XBRU:ARGX
|
56.4B EUR |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| AU |
|
CSL Ltd
ASX:CSL
|
80.6B AUD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Anterogen Co Ltd's probability of bankruptcy is Hidden .
The probability of bankruptcy is estimated using credit risk models that assess financial health, debt levels, interest coverage, and other solvency indicators.
As of the latest report, Anterogen Co Ltd has no debt.
You can find a full breakdown on its Balance Sheet.
